Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

IPSEN, OOO

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1929-01-01

Employees: 5.7K

Market Cap: $9.8B

Website: https://www.ipsen.com/

Clinical Trials

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

Completed

Conditions: Prostate Cancer

First Posted Date: 2023-03-08

Last Posted Date: 2024-11-01

Lead Sponsor: Ipsen

Target Recruit Count: 167

Registration Number: NCT05759273

Locations: 🇮🇹
Humanitas Gavazzeni, Bergamo, Italy
🇮🇹
AOU Policlinico "Gaspare Rodolico", Catania, Italy
🇮🇹
Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

and more 10 locations

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

Phase 2

Active, not recruiting

Conditions: Primary Sclerosing Cholangitis

Interventions: Drug: Elafibranor 120 mg
Drug: Elafibranor 80 mg
Drug: Placebo Matched to Elafibranor 120 mg
Drug: Placebo Matched to Elafibranor 80 mg

First Posted Date: 2022-11-25

Last Posted Date: 2025-06-19

Lead Sponsor: Ipsen

Target Recruit Count: 68

Registration Number: NCT05627362

Locations: 🇺🇸
Om Research LLC, Lancaster, California, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
University of California, Davis, Sacramento, California, United States

and more 59 locations

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Phase 3

Completed

Conditions: Locally Advanced Prostate Cancer
Advanced Prostate Cancer
Metastatic Prostate Cancer

Interventions: Drug: Triptorelin pamoate (embonate) salt

First Posted Date: 2022-10-21

Last Posted Date: 2024-08-28

Lead Sponsor: Ipsen

Target Recruit Count: 195

Registration Number: NCT05590793

Locations: 🇨🇳
Affiliated Hospital of Hebei University, Baoding, China
🇨🇳
Beijing Hospital, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, China

and more 33 locations

A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: elafibranor

First Posted Date: 2022-10-03

Last Posted Date: 2025-02-20

Lead Sponsor: Ipsen

Target Recruit Count: 34

Registration Number: NCT05564208

Locations: 🇫🇷
BIOTRIAL, Rennes, France

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Completed

Conditions: Spastic Hemiparesis
Muscle Spasticity

First Posted Date: 2022-09-19

Last Posted Date: 2023-04-18

Lead Sponsor: Ipsen

Target Recruit Count: 25

Registration Number: NCT05546190

Locations: 🇺🇸
Rancho Los Amigos National Rehab, Downey, California, United States
🇺🇸
MedStar National Rehabilitation Network, Washington, District of Columbia, United States

Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Elafibranor

First Posted Date: 2022-09-16

Last Posted Date: 2025-02-20

Lead Sponsor: Ipsen

Target Recruit Count: 48

Registration Number: NCT05543369

Locations: 🇺🇸
Collaborative Neuroscience Research LLC, Long Beach, California, United States
🇺🇸
Collaborative Neuroscience Research, LLC, Los Alamitos, California, United States

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: Triptorelin embonate 22.5 mg

First Posted Date: 2022-07-14

Last Posted Date: 2024-08-01

Lead Sponsor: Ipsen

Target Recruit Count: 147

Registration Number: NCT05458856

Locations: 🇧🇪
CHU de Liège - Domaine Universitaire du Sart Tilman - Urologie, Liège, Belgium
🇧🇪
Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇧🇪
UZ Antwerpen, Edegem, Belgium

and more 36 locations

A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

Completed

Conditions: Advanced Renal Cell Carcinoma

First Posted Date: 2022-07-06

Last Posted Date: 2023-07-18

Lead Sponsor: Ipsen

Target Recruit Count: 252

Registration Number: NCT05444933

Locations: 🇫🇷
CHU Amiens, Amiens, France
🇫🇷
CHU Angers, Angers, France
🇫🇷
Institut Sainte Catherine, Avignon, France

and more 24 locations

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

Completed

Conditions: Acromegaly

First Posted Date: 2022-06-24

Last Posted Date: 2025-01-31

Lead Sponsor: Ipsen

Target Recruit Count: 129

Registration Number: NCT05431803

Locations: 🇨🇳
Peking Union Medical College Hospital (PUMCH), Beijing, China
🇨🇳
Peking University Third Hospital (PUH3), Beijing, China
🇨🇳
Xiangya Hospital Central South University (XYHCSU), Changsha, China

and more 9 locations

A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Phase 1

Completed

Conditions: Metastatic Pancreatic Adenocarcinoma

Interventions: Drug: Irinotecan liposome injection
Drug: Folinic Acid
Drug: 5-Fluorouracil

First Posted Date: 2022-05-20

Last Posted Date: 2025-04-30

Lead Sponsor: Ipsen

Target Recruit Count: 177

Registration Number: NCT05383352

Locations: 🇦🇺
Flinders Medical Centre, Bedford Park, Australia
🇦🇺
Peninsula and Southeast Oncology - Frankston Private Hospital, Frankston, Australia
🇫🇷
Institut BERGONIE Centre de Lutte Contre le Cancer, Bordeaux, France

and more 33 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy